FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 329:1968-1969 December 23, 1993 Number 26 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article PubMed Citation

To the Editor: The case of vaccine-associated paralytic poliomyelitis reported by Mermel et al. (Sept. 9 issue)¹ raises important questions for public health policy. At current rates, some 80 cases of vaccine-associated paralytic poliomyelitis may be anticipated in the United States over the next 10 years². The immunocompetent man described by Mermel et al. contracted poliomyelitis although he had received a primary series of three doses of oral poliovirus vaccine (OPV). He did not, however, receive the recommended supplementary dose at school age to prevent the waning of immunity. This may have been the reason for his susceptibility. The . . . [Full Text of this Article]

References

Related Letters:

Vaccine-Associated Paralytic Poliomyelitis
Mermel L., de Mora D. S., Sutter R. W., Pallansch M. A.
Extract | Full Text  
N Engl J Med 1993; 329:810-811, Sep 9, 1993. Correspondence

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.